已发表论文

无症状性高尿酸血症和代谢异常的肥胖:天宁队列中的横断面分析

 

Authors Yu J, Sun H, Zhu J, Wei X, Shi H, Shen B, Ren L, He Y, Zhang R, Zhang M, Peng H

Received 14 January 2021

Accepted for publication 10 March 2021

Published 25 March 2021 Volume 2021:14 Pages 1367—1374

DOI https://doi.org/10.2147/DMSO.S301363

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Juei-Tang Cheng

Objective: The relationship between obesity and hyperuricemia has been demonstrated by many studies. However, whether or to what extent metabolic condition influents the association between obesity and hyperuricemia was not clear. Here, we aimed to examine the association between obese-metabolic phenotype and hyperuricemia in a large sample of Chinese adults.
Methods: According to BMI and metabolic syndrome, obese-metabolic phenotype was defined as metabolically unhealthy obesity (MUO), metabolically healthy obesity (MHO), metabolically unhealthy non-obesity (MUNO) and metabolically healthy non-obesity (MHNO)in the Tianning cohort (N=5072). We conducted a cross-sectional analysis between obese-metabolic phenotype and hyperuricemia, followed by a Mendelian Randomization analysis using GWAS summary data to confirm the causality between uric acid and BMI.
Results: The average level of serum UA showed 41.87-higher μmol/L in participants with MHO (β=41.87, < 0.001) and 63.18-higher μmol/L in participants with MUO (β=63.18, < 0.001), compared to those with MHNO. Compared to participants with MHNO, those with MUO had the highest likelihood to have hyperuricemia (OR=4.56, < 0.001), followed by those with MHO (OR=3.32, < 0.001). Mendelian randomization analysis indicated that uric acid was more likely to be a consequence of BMI (β=0.059, =6.54× 10− 154).
Conclusion: MUO, in comparison with MHO, was significantly associated with hyperuricemia in Chinese adults.
Keywords: metabolic syndrome, obesity, serum uric acid, hyperuricemia